Marc Scheineson is quoted on how the U.S. Food & Drug Administration can exercise its authority by requiring companies to register and list their cannabidiol products.
In the News
December 4, 2019
Inside Health Policy, FDA Week | Expert: FDA Should Require CBD Companies to Register, List Products
Media Contact